Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial
Background and objective: At present, there are common recommendations for treatment for stage II–III resectable rectal cancer patients: preoperative conventional chemoradiotherapy (CRT) with delayed surgery in 6–8 weeks or preoperative short-course radiotherapy (SCRT) followed by immediate surgery....
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2017-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1010660X17300460 |
| _version_ | 1827835711501369344 |
|---|---|
| author | Laura Kairevičė Tadas Latkauskas Algimantas Tamelis Aleksandras Petrauskas Henrikas Paužas Tadas Žvirblis Laimonas Jaruševičius Žilvinas Saladžinskas Dainius Pavalkis Rasa Jančiauskienė |
| author_facet | Laura Kairevičė Tadas Latkauskas Algimantas Tamelis Aleksandras Petrauskas Henrikas Paužas Tadas Žvirblis Laimonas Jaruševičius Žilvinas Saladžinskas Dainius Pavalkis Rasa Jančiauskienė |
| author_sort | Laura Kairevičė |
| collection | DOAJ |
| description | Background and objective: At present, there are common recommendations for treatment for stage II–III resectable rectal cancer patients: preoperative conventional chemoradiotherapy (CRT) with delayed surgery in 6–8 weeks or preoperative short-course radiotherapy (SCRT) followed by immediate surgery. The aim of this study was to compare overall survival (OS) and disease-free survival (DFS) in two treatment groups: preoperative SCRT and CRT both with delayed surgery plus adjuvant chemotherapy in CRT arm.
Materials and methods: A total of 150 patients were randomly assigned to two groups: 75 to CRT (preoperative conventional CRT, 50 Gy/25 fr with fluorouracil and leucovorin on the 1st and the 5th week of RT followed by TME surgery in 6–8 weeks and 4 cycles of adjuvant fluorouracil/leucovorin every 4 weeks; then follow-up) and 75 to SCRT (preoperative short-course RT, 25 Gy/5 fr followed by TME surgery in 6–8 weeks; then follow-up). The data of 140 patients (72 in CRT and 68 in SCRT group) were included in statistical analysis. Primary end points were OS and DFS.
Results: Median follow-up was 60.5 (range, 5–108) months. The 5-year DFS was 67% in the CRT group (n = 72) and 45% in the SCRT group (n = 68) (P = 0.013; HR = 1.88; 95% CI, 1.13–3.12; P = 0.015). The 5-year OS was 79% and 62% in the CRT and SCRT groups, respectively (P = 0.015; HR = 2.05; 95% CI, 1.13–3.70; P = 0.017). The 5-year OS for intent-to-treat (ITT) population (n = 150) was 78% in the CRT and 58% in the SCRT group (P = 0.003; HR = 2.28; 95% CI, 1.30–4.00; P = 0.004).
Conclusions: The 5-year DFS and OS were significantly better in the CRT than the SCRT group. For ITT population, OS was also significantly better after CRT versus SCRT. |
| first_indexed | 2024-03-12T06:13:04Z |
| format | Article |
| id | doaj.art-c2c2091a219342e1a496365e97b79b93 |
| institution | Directory Open Access Journal |
| issn | 1010-660X |
| language | English |
| last_indexed | 2024-03-12T06:13:04Z |
| publishDate | 2017-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-c2c2091a219342e1a496365e97b79b932023-09-03T02:50:40ZengMDPI AGMedicina1010-660X2017-01-0153315015810.1016/j.medici.2017.05.006Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trialLaura Kairevičė0Tadas Latkauskas1Algimantas Tamelis2Aleksandras Petrauskas3Henrikas Paužas4Tadas Žvirblis5Laimonas Jaruševičius6Žilvinas Saladžinskas7Dainius Pavalkis8Rasa Jančiauskienė9Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Chemotherapy with Day Care Unit, National Cancer Institute, Vilnius, LithuaniaDepartment of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaVilnius University Hospital Santariškių Klinikos, Vilnius, LithuaniaDepartment of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaBackground and objective: At present, there are common recommendations for treatment for stage II–III resectable rectal cancer patients: preoperative conventional chemoradiotherapy (CRT) with delayed surgery in 6–8 weeks or preoperative short-course radiotherapy (SCRT) followed by immediate surgery. The aim of this study was to compare overall survival (OS) and disease-free survival (DFS) in two treatment groups: preoperative SCRT and CRT both with delayed surgery plus adjuvant chemotherapy in CRT arm. Materials and methods: A total of 150 patients were randomly assigned to two groups: 75 to CRT (preoperative conventional CRT, 50 Gy/25 fr with fluorouracil and leucovorin on the 1st and the 5th week of RT followed by TME surgery in 6–8 weeks and 4 cycles of adjuvant fluorouracil/leucovorin every 4 weeks; then follow-up) and 75 to SCRT (preoperative short-course RT, 25 Gy/5 fr followed by TME surgery in 6–8 weeks; then follow-up). The data of 140 patients (72 in CRT and 68 in SCRT group) were included in statistical analysis. Primary end points were OS and DFS. Results: Median follow-up was 60.5 (range, 5–108) months. The 5-year DFS was 67% in the CRT group (n = 72) and 45% in the SCRT group (n = 68) (P = 0.013; HR = 1.88; 95% CI, 1.13–3.12; P = 0.015). The 5-year OS was 79% and 62% in the CRT and SCRT groups, respectively (P = 0.015; HR = 2.05; 95% CI, 1.13–3.70; P = 0.017). The 5-year OS for intent-to-treat (ITT) population (n = 150) was 78% in the CRT and 58% in the SCRT group (P = 0.003; HR = 2.28; 95% CI, 1.30–4.00; P = 0.004). Conclusions: The 5-year DFS and OS were significantly better in the CRT than the SCRT group. For ITT population, OS was also significantly better after CRT versus SCRT.http://www.sciencedirect.com/science/article/pii/S1010660X17300460Rectal cancerChemoradiotherapyRadiotherapy |
| spellingShingle | Laura Kairevičė Tadas Latkauskas Algimantas Tamelis Aleksandras Petrauskas Henrikas Paužas Tadas Žvirblis Laimonas Jaruševičius Žilvinas Saladžinskas Dainius Pavalkis Rasa Jančiauskienė Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial Medicina Rectal cancer Chemoradiotherapy Radiotherapy |
| title | Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial |
| title_full | Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial |
| title_fullStr | Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial |
| title_full_unstemmed | Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial |
| title_short | Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial |
| title_sort | preoperative long course chemoradiotherapy plus adjuvant chemotherapy versus short course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage ii iii resectable rectal cancer 5 year survival data of a randomized controlled trial |
| topic | Rectal cancer Chemoradiotherapy Radiotherapy |
| url | http://www.sciencedirect.com/science/article/pii/S1010660X17300460 |
| work_keys_str_mv | AT laurakairevice preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT tadaslatkauskas preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT algimantastamelis preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT aleksandraspetrauskas preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT henrikaspauzas preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT tadaszvirblis preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT laimonasjarusevicius preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT zilvinassaladzinskas preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT dainiuspavalkis preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial AT rasajanciauskiene preoperativelongcoursechemoradiotherapyplusadjuvantchemotherapyversusshortcourseradiotherapywithoutadjuvantchemotherapybothwithdelayedsurgeryforstageiiiiiresectablerectalcancer5yearsurvivaldataofarandomizedcontrolledtrial |